Each year more than 130,000 people die from a type of heart arrhythmia called atrial fibrillation. Up to six million people in the United States alone may be living with the abnormal heart rhythm, according to the Centers for Disease Control and Prevention.
That’s why when the drug Xarelto was introduced in 2011 as a newer and safer way to reduce the risk of stroke and blood clots in those with atrial fibrillation, people were excited.
Patients quickly discovered Xarelto was not as safe as it seemed, as they became injured or died from unexpected side effects like severe bleeding. Now more than 20,000 federal lawsuits have been filed against the makers of the blood thinner over claims that they failed to warn the public about potentially deadly side effects.